We are live on ! Find out more
BKYI

BIO-key International
BKYI

10 hedge funds and large institutions have $399K invested in BIO-key International in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

248% more capital invested

Capital invested by funds: $115K → $399K (+$284K)

1.4% more ownership

Funds ownership: 0.22% → 1.61% (+1.4%)

9% less funds holding

Funds holding: 11 → 10 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$560K
2
TSS
Two Sigma Securities
New York
+$32.3K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$13.3K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$34.8K
2
XT
XTX Topco
Cayman Islands
-$17.5K
3
TRCT
Tower Research Capital (TRC)
New York
-$6.49K
4
Citigroup
Citigroup
New York
-$2.69K
5
VF
Virtu Financial
New York
-$877

BKYI Hedge Fund Activity: Q1 2025 in Review

10 institutional investors reported a position in BIO-key International (BKYI) for Q1 2025, worth a combined $399K — up 248% from $115K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BKYI and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $560K. The largest seller was Citadel Advisors, exiting entirely with an estimated $34.8K sold.

  • 10 institutional investors held BIO-key International (BKYI) as of Q1 2025, down from 11 in Q4 2024.
  • Funds reported $399K of BIO-key International stock for Q1 2025, up 248% quarter-over-quarter.
  • 2 funds opened new BIO-key International positions in Q1 2025 and 3 closed out, a net change of -1 holder.
  • The largest BIO-key International buyer in Q1 2025 was Armistice Capital, an estimated $560K added.
  • The largest BIO-key International seller in Q1 2025 was Citadel Advisors, an estimated $34.8K sold.

Based on aggregated 13F filings for Q1 2025.